Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country.

Fekadu, Ginenus; Jiang, Xinchan; Yao, Jiaqi; You, Joyce H S

Fekadu, Ginenus; Jiang, Xinchan; Yao, Jiaqi; You, Joyce H S.

Afiliación

Fekadu G; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Jiang X; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Yao J; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
You JHS; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address: joyceyou@cuhk.edu.hk.

Int J Infect Dis ; 113: 271-278, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34688946

Asunto(s)

COVID-19; Tuberculosis; Adulto; Antituberculosos/uso terapéutico; Análisis Costo-Beneficio; Años de Vida Ajustados por Discapacidad; Humanos; Pandemias; SARS-CoV-2; Tuberculosis/epidemiología

Palabras clave

COVID-19 pandemic; Cost-effectiveness; High income; Tuberculosis; Video-observed therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / COVID-19 Tipo de estudio: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Límite: Adult / Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google